Thus, in the model in which tumor-derived antigen could be presented to T-cell receptor-transgenic (TCR-tg) CD4+ T cells by host but not tumor MHC-II molecules, adoptive transfer of pre-activated CD4+ T cells was able to control the growth of tumors in some lymphopenic hosts (24). Here, CD4 is linked to neoplasm.